Back to Search

PEGGY KRAUS, PHARMD

PHARMD

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

NPI: 1487984746Individual

Specialties, Licenses & Credentials

Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary

Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Code: 1835P0018X

16690(MD)

Research & Publications (20)

Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device.
PMID 19086085·Mov Disord·2009
8-other
Decreasing uptake of predictive testing for Huntington's disease in a German centre: 12 years' experience (1993-2004).
PMID 18781186·Eur J Hum Genet·2009
8-other
Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb.
PMID 19136965·Nat Cell Biol·2009
7-preclinical
Huntington's disease as caused by 34 CAG repeats.
PMID 18307262·Mov Disord·2008
5-case
Desulfovibrio carbinoliphilus sp. nov., a benzyl alcohol-oxidizing, sulfate-reducing bacterium isolated from a gas condensate-contaminated aquifer.
PMID 18523171·Int J Syst Evol Microbiol·2008
8-other
ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.
PMID 18327563·J Mol Med (Berl)·2008
8-other
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.
PMID 17571346·Nature·2007
8-other
Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI.
PMID 17546670·Mov Disord·2007
8-other
Riluzole in Huntington's disease: a 3-year, randomized controlled study.
PMID 17702031·Ann Neurol·2007
4-observational
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.
PMID 17569088·Hum Genet·2007
4-observational
Simulation and virtual reality in medical education and therapy: a protocol.
PMID 16640488·Cyberpsychol Behav·2006
8-other
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.
PMID 16507108·BMC Neurol·2006
3-trial
No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.
PMID 17096834·BMC Med Genet·2006
8-other
Initial evaluation of N,N-diethyl-m-toluamide and permethrin absorption in human volunteers under stress conditions.
PMID 16578980·Mil Med·2006
2-rct
Changing dopamine agonist treatment in Parkinson's disease: experiences with switching to pramipexole.
PMID 17447411·J Neural Transm Suppl·2006
4-observational
Dlx homeobox gene control of mammalian limb and craniofacial development.
PMID 16688724·Am J Med Genet A·2006
6-review
Kinetic tremor in Parkinson's disease--an underrated symptom.
PMID 16804646·J Neural Transm (Vienna)·2006
8-other
Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.
PMID 17036555·Mayo Clin Proc·2006
4-observational
Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD).
PMID 16202123·BMC Med Genet·2005
8-other
[Amisulpride in Huntington's disease].
PMID 16220421·Psychiatr Prax·2005
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1830 E MONUMENT ST, SUITE 7300
BALTIMORE, MD 21287

Location

Practice Location

1830 E MONUMENT ST, BALTIMORE, MD
(410) 502-0464

Quick Facts

NPI
1487984746
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile